Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study

Neurogenic lower urinary tract dysfunction (NLUTD) results from neurological issues, impacting bladder control. Symptoms vary depending on the specific neurological problem, including overactive bladder, loss of coordination, and retention. Typical treatments include medications and injections; however, neuromodulation, which involves implantable devices to stimulate nerves, is emerging as another option, even for those with neurological disorders. This study reviews the use of sacral and pudendal neuromodulation in patients with neurogenic bladder at a single hospital, examining patient outcomes and symptom changes following the treatment.

• 1
  Neuromodulation, both sacral and pudendal, is a feasible and effective treatment option for NLUTD, with a significant percentage of patients experiencing symptom improvement.
• 2
  The most common neurologic diagnoses in the study population were diabetic cystopathy, spinal surgery, and spinal cord injury.
• 3
  Pudendal neuromodulation demonstrated similar or improved efficacy compared to sacral neuromodulation in select patients, particularly those with abnormal sacral anatomy or significant pelvic pain.